PT792165E - Composicoes imunogenicas - Google Patents

Composicoes imunogenicas

Info

Publication number
PT792165E
PT792165E PT95936690T PT95936690T PT792165E PT 792165 E PT792165 E PT 792165E PT 95936690 T PT95936690 T PT 95936690T PT 95936690 T PT95936690 T PT 95936690T PT 792165 E PT792165 E PT 792165E
Authority
PT
Portugal
Prior art keywords
immunogenic compositions
immunogenic composition
solubilised
immunogen
absence
Prior art date
Application number
PT95936690T
Other languages
English (en)
Inventor
Roger Randal Charles New
Original Assignee
Vaxcine Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vaxcine Ltd filed Critical Vaxcine Ltd
Publication of PT792165E publication Critical patent/PT792165E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
PT95936690T 1994-11-15 1995-11-14 Composicoes imunogenicas PT792165E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9422990A GB9422990D0 (en) 1994-11-15 1994-11-15 Immunogenic compositions

Publications (1)

Publication Number Publication Date
PT792165E true PT792165E (pt) 2004-02-27

Family

ID=10764393

Family Applications (1)

Application Number Title Priority Date Filing Date
PT95936690T PT792165E (pt) 1994-11-15 1995-11-14 Composicoes imunogenicas

Country Status (19)

Country Link
EP (1) EP0792165B1 (pt)
JP (1) JP4297515B2 (pt)
KR (1) KR970706848A (pt)
CN (1) CN100346828C (pt)
AT (1) ATE249841T1 (pt)
AU (1) AU700910B2 (pt)
CA (1) CA2205083A1 (pt)
DE (1) DE69531793T2 (pt)
DK (1) DK0792165T3 (pt)
ES (1) ES2210318T3 (pt)
FI (1) FI972054A0 (pt)
GB (1) GB9422990D0 (pt)
IL (1) IL116010A0 (pt)
MX (1) MX9703480A (pt)
NO (1) NO972219L (pt)
NZ (1) NZ295238A (pt)
PT (1) PT792165E (pt)
WO (1) WO1996014871A1 (pt)
ZA (1) ZA959729B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9323588D0 (en) 1993-11-16 1994-01-05 Cortecs Ltd Hydrophobic preparation
US6165773A (en) * 1995-10-25 2000-12-26 Provalis Uk Limited Methods of preserving viruses
GB9613858D0 (en) 1996-07-02 1996-09-04 Cortecs Ltd Hydrophobic preparations
AR013202A1 (es) * 1997-07-10 2000-12-13 Biotech Australia Pty Ltd Vacunas no acuosas
AU736038C (en) * 1997-07-10 2006-08-10 Intervet Australia Pty Limited Non-aqueous vaccines
US6488936B1 (en) * 1998-02-12 2002-12-03 Wyeth Immunogenic composition of interleukin-12 (IL-12), alum, herpes simplex viral (HSV) antigen, and method thereof
EP1053016A2 (en) * 1998-02-12 2000-11-22 American Cyanamid Company Vaccines comprising interleukin-12 and respiratory syncytial viral antigens
AU759391B2 (en) * 1998-02-12 2003-04-10 Wyeth Holdings Corporation Pneumococcal and meningococcal vaccines formulated with interleukin-12
ATE375803T1 (de) * 1998-05-07 2007-11-15 Corixa Corp Adjuvanszusammensetzung und methoden zu deren verwendng
US7534443B1 (en) 1998-07-16 2009-05-19 Ichiro Azuma Preparations for immunotherapy for cancer having bacterial somatic constituent as the active ingredient
CN106310293A (zh) 2007-09-27 2017-01-11 免疫疫苗技术有限公司 在包括连续疏水相的载体中的脂质体在体内输送多核苷酸中的应用
CA2700828C (en) * 2007-10-03 2017-01-24 Immunovaccine Technologies Inc. Compositions comprising an antigen, an amphipathic compound and a hydrophobic carrier, and uses thereof
AU2009253780B2 (en) 2008-06-05 2014-08-14 Immunovaccine Technologies Inc. Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance
EP2654782A4 (en) * 2010-12-23 2015-03-25 Immport Therapeutics Inc PROCESSES AND COMPOSITIONS FROM PROTEIN ANTIGEN FOR THE DIAGNOSIS AND TREATMENT OF TOXOPLASMA GONDII INFECTIONS AND TOXOPLASMOSIS
GB201107629D0 (en) * 2011-05-06 2011-06-22 Proxima Concepts Ltd Hydrophobic preparations
CN102277373B (zh) * 2011-08-15 2014-07-02 南京大学 一种减毒沙门氏菌分泌表达的日本血吸虫疫苗表达载体及其应用
EP2763698B1 (en) 2011-10-06 2020-12-02 ImmunoVaccine Technologies Inc. Liposome compositions comprising an adjuvant that activates or increases the activity of tlr2 and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4578391A (en) * 1982-01-20 1986-03-25 Yamanouchi Pharmaceutical Co., Ltd. Oily compositions of antitumor drugs
IE904098A1 (en) * 1989-11-13 1991-05-22 Nova Pharm Corp Lipospheres for controlled delivery of substances
DK0521562T3 (da) * 1991-06-26 2003-07-14 Yamanouchi Europ Bv Vesikler i ikke-polære medier
DE69418334T2 (de) * 1993-08-06 2000-01-27 Opperbas Holding B.V., Amsterdam Verfahren zur hohen beladung von vesikeln mit biopolymeren substanzen
GB9323588D0 (en) * 1993-11-16 1994-01-05 Cortecs Ltd Hydrophobic preparation

Also Published As

Publication number Publication date
NO972219L (no) 1997-07-11
FI972054A (fi) 1997-05-14
EP0792165B1 (en) 2003-09-17
IL116010A0 (en) 1996-01-31
FI972054A0 (fi) 1997-05-14
CN1163575A (zh) 1997-10-29
KR970706848A (ko) 1997-12-01
CN100346828C (zh) 2007-11-07
AU3853495A (en) 1996-06-06
DE69531793T2 (de) 2004-07-15
ATE249841T1 (de) 2003-10-15
JP4297515B2 (ja) 2009-07-15
ES2210318T3 (es) 2004-07-01
DK0792165T3 (da) 2004-01-05
CA2205083A1 (en) 1996-05-23
JPH10508834A (ja) 1998-09-02
AU700910B2 (en) 1999-01-14
GB9422990D0 (en) 1995-01-04
EP0792165A1 (en) 1997-09-03
DE69531793D1 (de) 2003-10-23
WO1996014871A1 (en) 1996-05-23
ZA959729B (en) 1997-05-15
NO972219D0 (no) 1997-05-14
MX9703480A (es) 1997-08-30
NZ295238A (en) 1999-01-28

Similar Documents

Publication Publication Date Title
PT792165E (pt) Composicoes imunogenicas
IT1229845B (it) Procedimento per la preparazione di perfluoropolieteri perossidici.
WO1997001640A3 (en) Vaccines against hepatitis c
MA22842A1 (fr) Procede de preparation de compositions de vaccin.
DK1382348T3 (da) Polynukleotidvaccineformulering, især til behandling af bovin luftvejssygdom
DE19875032I2 (de) Mometason-Furoate-Monohydrat, Verfahren zu seiner Herstellung und das enthaltende pharmazeutische Zusammensetzungen
AU4622693A (en) Potentiation of immunogenic response
NO911949D0 (no) Tgf-beta-preparater.
DZ2283A1 (fr) Composition de vaccin.
NO912825D0 (no) Fremgangsmaate for fremstilling av cokonjugate vaksiner omfattende immunogenisk protein, hiv-beslektede peptider og anioniske grupper.
NO894588L (no) Kosmetisk fremstilling som inneholder chitosan.
DE69738271D1 (de) Rotavirus-impfstoff
IL98262A (en) Chromone derivatives and pharmaceutical compositions containing them
BR9704879A (pt) Composição de vacina e uso de um vírus cav vivo
BR0009077A (pt) Antìgenos de tuberculose e métodos de uso dos mesmos
DK150604C (da) Analogifremgangsmaade til fremstilling af calciumoxaprozin
ATE227122T1 (de) Stabilisierte tablettenformulierung
AU7528087A (en) Immunogenic fraction active against bilharzioses, its preparation, and immunizing compositions containing it
CA2078985A1 (fr) Composition vaccinale contre la grippe, a effet synergique, contenant comme additif du core de virus grippal
NO961429D0 (no) Fremgangsmåte for fremstilling av kinolonholdige, orale preparater
DE69614552D1 (de) MODIFIZIERTE ALPHA-D-GLCP-(1,2)-ALPHA-D-Glcp-(1,3)-ALPHA-D-Glcp-ANALOGE
ATE60765T1 (de) Pyranderivate.
MX9204323A (es) Procedimiento para la preparacion de derivados de taxano.
SE8503513D0 (sv) Farmaceutiska och kosmetiska kompositioner, vilka som verksam bestandsdel innehaller acetyl-10-triacetoxi-1,8,9-antracen
IT8919110A0 (it) Peptidi sintetici e loro uso come carriers universali per la preparazione di coniugati immunogenici adatti per lo sviluppo di vaccini sintetici.